Retroprosthetic Membrane Formation in Boston Keratoprosthesis Type 1: Incidence, Predisposing Factors, Complications,

Diana Khair1, Roy Daoud, Mona Harissi-Dagher

  • 1Department of Ophthalmology, Université de Montréal, Montréal, Québec, Canada.

Cornea
|October 8, 2021
PubMed
Abstract

Insights

Retroprosthetic membrane (RPM) affects 39% of patients after Boston type 1 keratoprosthesis (BKPro) implantation. Monitoring for retinal detachment is crucial, and Nd:YAG membranectomy offers a potential treatment.

Area of Science:

  • Ophthalmology
  • Corneal Surgery
  • Prosthetic Eye Implants

Background:

  • Boston type 1 keratoprosthesis (BKPro) is a treatment for corneal blindness.
  • Retroprosthetic membrane (RPM) formation is a known complication after BKPro implantation.
  • Understanding RPM incidence, risk factors, and outcomes is vital for patient management.

Purpose of the Study:

  • To determine the incidence and formation rate of RPM after BKPro.
  • To identify preoperative and intraoperative risk factors for RPM development.
  • To analyze secondary complications and treatment outcomes for RPM.

Main Methods:

  • Retrospective cohort study of 133 eyes (115 patients) with BKPro.
  • Data collected included RPM incidence, risk factors, complications, and treatments.
  • Minimum 1-year follow-up was required for inclusion.

Main Results:

  • 39% of eyes developed RPM with a mean follow-up of 5.5 years.
  • Simultaneous lens extraction increased RPM risk (OR=2.65), while intraocular lens extraction decreased it (OR=0.36).
  • RPM was strongly associated with retinal detachment (OR=6.16), hypotony, and corneal melt. Nd:YAG membranectomy resolved RPM in 58% of cases.

Conclusions:

  • Over one-third of BKPro patients develop RPM, necessitating vigilant monitoring for complications like retinal detachment.
  • Simultaneous lens extraction is a risk factor, whereas intraocular lens extraction appears protective against RPM.
  • Nd:YAG membranectomy is an effective initial noninvasive treatment for RPM.